甘草苷|Liquiritin|cas:551-15-5|西域试剂

甘草苷,Liquiritin,分析标准品,HPLC≥99.1%

产品编号：西域质检-TM61101| CAS NO：551-15-5| 分子式：C₂₁H₂₂O₉| 分子量：418.39

Liquiritin 是一种从甘草中得到的黄酮类化合物，为抗氧化剂，具有神经保护、抗癌、抗炎的活性。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	包装	价格	库存与货期	购买量	操作
西域质检-TM61101		￥650.00	杭州北京（现货）
西域质检-TM61101		￥1500.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

甘草苷

Reference Material

This certificate is designed in accordance with ISO 17034 and ISO Guide 31. This reference material (RM) was designed,produced and verified in accordance with ISO/IEC 17025, ISO 17034 and a registered quality management system ISO 9001.

Product Name(产品名称) Liquiritin

Product Code(产品编号) 717127-10mg

Lot Number(产品批号) 22010676

CAS No. 551-15-5

Mol. Weight(分子量) 418.39

Mol. Formula(分子式) C₂₁H₂₂O₉

Melting Point(熔点) N/A

Expiry Date(失效日期) 2029-Jan-25

Boiling point(沸点) N/A

Appearance(外观) White to Off-White Solid

Storage Temp(存储条件) (2~8)℃,Keep in the shade

C E R T I F I E D

Purity

99.1%

C E R T I F I E D

Expanded Uncertainty (U)

0.5%

Uncertainty

The certified value(s) and uncertainty(ies) are determined in accordance with ISO 17034 with an 95% confidence level(k=2). Uncertainty is based on the Total Combined Uncertainty, including uncertainties of characterisation, homogeneity and stability testing. Stability values are based on real evidence opposed to simulation.

Traceability

The balances used for gravimetric measurements are calibrated with weights traceable to the national standards. The calibration of the balances is verified annually by an external accredited calibration service. This analysis method has been verified using an approach consistent with ISO 17034:2016 & ISO 17025:2017.

CERTIFICATE ON	QC SIGNATURE
2022-Jan-26		RM Release

Method of Identification

HPLC

Method of Identification

HPLC

Intended Use

This RM is intended for use in a laboratory as a calibration and quality control standard or in method development for analytical techniques.

Storage

This reference material meets the specification stated in this certificate until the expiry date, provided it is stored unopened at the recommended temperature here in. If storage after opening is necessary, the RM should be tightly closed and kept from light and moisture.

Hazards

Read Material Safety Data Sheet (MSDS) and understand any potential hazard(s) prior to the use of this product. All chemicals should be considered potentially hazardous in nature and should only be handled by qualified personnel using established good laboratory practices.

Homogeneity

Random replicate samples of the final packaged RM have been analysed to prove homogeneity compliant with ISO 17034.

Instructions for use

It is recommended to use 1 mg as the minimum sample size and if less material is used, to increase the certified uncertainty by a factor of two for half sample and four for a quarter of sample.Visit the support section of our website technology videos and frequently asked questions.

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

危险品运输编码	NONH for all modes of transport
海关编码	29389090

1. 物质的识别

产品名：	Liquiritin
CAS号：	551-15-5
制造商/供应商：	西域试剂网站：www.hzbp.cn 邮件：13911702513@139.com

2. 合成/成分数据

产品名：	Liquiritin
分子式：	C21H22O9
分子量：	418.394

3. 急救措施

吸入后：	如果吸入，移至空气新鲜处，如果呼吸困难，给输氧，如呼吸停止，给予人工呼吸。
皮肤接触后：	用大量的水冲洗，移除污染的衣服和鞋子。
眼睛接触后：	检查并取下隐形眼镜，并用大量的水冲洗；呼叫医生。
吞食后：	如果吞食，用大量纯净水漱口；呼叫医生。

4. 消防措施

适当的灭火剂：	雾状水，二氧化碳，干粉或泡沫。
防护设备：	穿戴自给式呼吸器和防护服，以防止与皮肤和眼睛接触。

5. 泄漏应急处理

安全防范措施：	封锁泄漏区域；穿戴自给式呼吸器，防护服和厚橡胶手套。
清洁/收集措施：	使用液体粘合原料（硅藻土，通用粘合剂）吸取精细粉末；使用酒精擦洗表面和设备除去污渍；根据第11条处理被污染的材料。

6. 处理和储存

安全处理说明：	避免吸入和接触皮肤，眼睛及衣物；材料可能略微具有刺激性。
储存：	粉末型式 -20°C 3年；4°C 2年溶于溶剂 -80°C 6个月；-20°C 1个月

7. 接触控制和个人防护

呼吸设备：	NIOSH / MSHA认可的呼吸器。
双手保护：	耐化学腐蚀的橡胶手套。
眼睛防护：	化学安全护目镜。

8. 稳定性和反应活性

稳定性：	按照说明存储是稳定的；避免强氧化剂。
热分解/其他要避免的情况：	避免光和热。

9. 毒性资料

急性毒性：	无可用资料。
主要刺激性影响：	无可用资料。
在皮肤上：	无可用资料。
对眼睛：	无可用资料；可能具有刺激性。

10. 生态资料

一般注意事项：

无可用资料。

11. 废弃处置

按照所在国家，省份，县市和地方的法规处置。

12. 运输信息

正确的运输名称：	无
非危险品运输：	这种物质被视为非危险品运输。

13. 法规信息

尚未有针对此产品作出的化学安全性评估。

14. 其他信息

上游产品 0
下游产品 3
578-86-9 32274-71-8 95753-46-1

86. [3.614] Shu-Yun Yang et al."An integrated approach of HPLC-MS-based chemical profiling, network pharmacology, and molecular docking to reveal the potential mechanisms of Qishen Gubiao Granules for treating COVID-19."JOURNAL OF SEPARATION SCIENCE.2023 Mar;:2200953

85. [3.614] Yumin Cao et al."Comparative pharmacokinetic studies of Ephedra herba in common cold and nephrotic syndrome rat models."JOURNAL OF SEPARATION SCIENCE.2023 Feb;:2200895

84. [6.656] Lin Sun et al."Exploration of the anti-liver injury active components of Shaoyao Gancao decoction by network pharmacology and experiments in vivo."PHYTOMEDICINE.2023 Feb;:154717

83. [5.195] Bao-Fei Yan et al."Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway."JOURNAL OF ETHNOPHARMACOLOGY.2023 Mar;303:115999

82. [5.195] Xiaojing Wang et al."Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice."JOURNAL OF ETHNOPHARMACOLOGY.2022 Nov;:115919

81. [IF=2.65] Bin Wang et al."Xiaoqinglong Decoction Enhances Autophagy to Antagonist Airway Inflammation Induced by Cold in Asthmatic Rats."Evidence-based Complementary and Alternative Medicine.2022 Oct 25;2022:3943343

80. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199

79. [IF=5.195] Yuying Zheng et al."Shashen-Maidong Decoction inhibited cancer growth under intermittent hypoxia conditions by suppressing oxidative stress and inflammation."JOURNAL OF ETHNOPHARMACOLOGY.2022 Dec;299:115654

78. [IF=6.208] Pan Wang et al."Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(18):10747

77. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231

76. [IF=6.656] Di Deng et al."Sinisan alleviates depression-like behaviors by regulating mitochondrial function and synaptic plasticity in maternal separation rats."PHYTOMEDICINE.2022 Aug;:154395

75. [IF=5.195] Zehua Jin et al."Network pharmacology study to reveal active compounds of Qinggan Yin formula against pulmonary inflammation by inhibiting MAPK activation."JOURNAL OF ETHNOPHARMACOLOGY.2022 Oct;296:115513

74. [IF=1.978] Chen Ming-jun et al."Composite Sophora Colon-Soluble Capsule Ameliorates DSS-Induced Ulcerative Colitis in Mice via Gut Microbiota-Derived Butyric Acid and NCR+ ILC3."Chin J Integr Med. 2022 Apr;:1-10

73. [IF=2.63] Zhou Peng et al."Exploring the Mechanism of Ling-Gui-Zhu-Gan Decoction in Ventricular Remodeling after Acute Myocardial Infarction Based on UPLC and In Vivo Experiments."Evidence-based Complementary and Alternative Medicine. 2022;2022:8593176

72. [IF=2.63] Sun Ke-han et al."Comparative Pharmacokinetics of Seven Major Compounds in Normal and Atherosclerosis Mice after Oral Administration of Simiao Yong’an Decoction."Evidence-based Complementary and Alternative Medicine. 2022;2022:4604601

71. [IF=5.34] Dong Shao et al."Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology."PHYTOMEDICINE. 2022 Jul;102:154177

70. [IF=4.412] Haifan Liu et al."Pharmacokinetics, Prostate Distribution and Metabolic Characteristics of Four Representative Flavones after Oral Administration of the Aerial Part of Glycyrrhiza uralensis in Rats."MOLECULES. 2022 Jan;27(10):3245

69. [IF=4.36] Shasha Kong et al."Synergistic mechanism for the bioactivity fortification of licorice by honey."J Ethnopharmacol. 2022 May;289:115048

68. [IF=1.902] Jia Wang et al."Investigate the effect of honey on the absorption of seven active ingredients from wu-tou decoction in rats."Biomedical Chromatography. 2022 Jan 06

67. [IF=5.545] Yuxuan Han et al."Multi-dimensional "projection" - the impact of abiotic stresses on the content of seven active compounds and expression of related genes in Glycyrrhiza uralensis Fisch."Environ Exp Bot. 2022 May;197:104846

66. [IF=2.629] Mo Jiajia et al."Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway."Evid-Based Compl Alt. 2022;2022:7861338

65. [IF=1.885] Xia Wenxin et al."Study on the Spectrum-Effect Relationship of the Traditional Effect of Saponins in Glycyrrhiza uralensis Fisch."Int J Anal Chem. 2021;2021:6617033

64. [IF=1.902] Chenxi Wang et al."Multiple component-pharmacokinetic studies on 10 bioactive constituents of Peiyuan Tongnao capsule using parallel reaction monitoring mode."Biomed Chromatogr. 2021 Oct;35(10):e5153

63. [IF=2.629] Li Tingting et al."Quality Assessment of Licorice Based on Quantitative Analysis of Multicomponents by Single Marker Combined with HPLC Fingerprint."Evid-Based Compl Alt. 2021;2021:8834826

62. [IF=3] Wan Haoyu et al."Pharmacokinetics of seven major active components of Mahuang decoction in rat blood and brain by LC–MS/MS coupled to microdialysis sampling."N-S Arch Pharmacol. 2020 Aug;393(8):1559-1571

61. [IF=3.935] Pengcheng Huang et al."Correlation study between the pharmacokinetics of seven main active ingredients of Mahuang decoction and its pharmacodynamics in asthmatic rats."J Pharmaceut Biomed. 2020 May;183:113144

60. [IF=4.142] Wang Chenxi et al."Systematic quality evaluation of Peiyuan Tongnao capsule by offline two-dimensional liquid chromatography/quadrupole-Orbitrap mass spectrometry and adjusted parallel reaction monitoring of quality markers."Anal Bioanal Chem. 2019 Nov;4

59. [IF=4.225] Wei Wenyang et al."Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A."Front Pharmacol. 2019 Sep;0:961

58. [IF=4.36] Li-Mei Feng et al."An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropathic pain by the combination of partial least-squares regression and multi-index comprehensive method."J Ethnopharmacol. 2020 Oc

57. [IF=4.36] Yang Zhao et al."Shashen-Maidong Decoction improved chronic intermittent hypoxia-induced cognitive impairment through regulating glutamatergic signaling pathway."J Ethnopharmacol. 2021 Jun;274:114040

56. [IF=4.36] Li Lin et al."Study on the alleviation of Fengshi Gutong capsule on rheumatoid arthritis through integrating network pharmacology and experimental exploration."J Ethnopharmacol. 2021 Nov;280:114471

55. [IF=4.874] Zhenhong Liu et al."Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury."Cell Calcium. 2020 Jun;88:102198

54. [IF=5.279] Yanan Gao et al."Galactosylation of Monosaccharide Derivatives of Glycyrrhetinic Acid by UDP-Glycosyltransferase GmSGT2 from Glycine max."J Agr Food Chem. 2020;68(32):8580–8588

53. [IF=5.34] Jing Zhang et al."Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule."Phytomedicine. 2020 Oct;77:153273

52. [IF=5.64] Ting Li et al."Dynamic Changes in Endophytic Microorganisms and Metabolites During Natural Drying of Licorice."Front Microbiol. 2021; 12: 740721

51. [IF=5.81] Cui Lihua et al."Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway."Front Pharmacol. 2021 Jun;0:1369

50. [IF=6.953] Dan Jiang et al."Molecular cloning and functional characterization of UGTs from Glycyrrhiza uralensis flavonoid pathway."Int J Biol Macromol. 2021 Dec;192:1108

49. [IF=11.413] Yan Yin et al."De novo biosynthesis of liquiritin in Saccharomyces cerevisiae."Acta Pharm Sin B. 2020 Apr;10:711

48. [IF=2.896] Hui-Long Luo et al."A systematic quality control method of Huangqi decoction: simultaneous determination of eleven flavonoids and seven triterpenoid saponins by UHPLC-MS."Anal Methods-Uk. 2014 Jun;6(13):4593-4601

47. [IF=3] Han CHEN et al."Chemical profile of the active fraction of Yi-Gan San by HPLC-DAD-Q-TOF-MS and its neuroprotective effect against glutamate-induced cytotoxicity."Chin J Nat Medicines. 2014 Nov;12:869

46. [IF=3.361] Li Ma et al."Characterization of the global metabolic profile of liquiritin in rat plasma, urine, bile and feces based on UHPLC-FT-ICR MS."Rsc Adv. 2018 Feb;8(11):5945-5952

45. [IF=3.414] Mengkai Zheng et al."Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model."J Ethnopharmacol. 2015 Apr;164:22

44. [IF=3.922] Wei Wang et al."Peony-Glycyrrhiza Decoction, an Herbal Preparation, Inhibits Clozapine Metabolism via Cytochrome P450s, but Not Flavin-Containing Monooxygenase in In Vitro Models."Drug Metab Dispos. 2015 Jul;43(7):1147-1153

43. [IF=4.411] Jifeng Gu et al."Application of High-Performance Liquid Chromatography Coupled with Linear Ion Trap Quadrupole Orbitrap Mass Spectrometry for Qualitative and Quantitative Assessment of Shejin-Liyan Granule Supplements."Molecules. 2018 Apr;23(4):884

42. [IF=6.057] Zhihong Li et al."New MS network analysis pattern for the rapid identification of constituents from traditional Chinese medicine prescription Lishukang capsules in vitro and in vivo based on UHPLC/Q-TOF-MS."Talanta. 2018 Nov;189:606

41. Valkó, Klára. "Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution." Journal of chromatography A 1037.1-2 (2004): 299-310.https://doi.org/10.1016/j.chroma.2003.10.084

40. Valkó, Klára. "Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution." Journal of chromatography A 1037.1-2 (2004): 299-310.https://doi.org/10.1016/j.chroma.2003.10.084

39. Zhang, Jing, et al. "Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule." Phytomedicine 77 (2020): 153273.https://doi.org/10.1016/j.phymed.2020.153273

38. Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan, An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropa

37. Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan, An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropa

36. Han, C. H. E. N., et al. "Chemical profile of the active fraction of Yi-Gan San by HPLC-DAD-Q-TOF-MS and its neuroprotective effect against glutamate-induced cytotoxicity." Chinese journal of natural medicines 12.11 (2014): 869-880.https://doi.org/10.1016/

35. Zheng, Mengkai, et al. "Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model." Journal of ethnopharmacology 164 (2015): 22-29.https://

34. Ma, Li, et al. "Characterization of the global metabolic profile of liquiritin in rat plasma, urine, bile and feces based on UHPLC-FT-ICR MS." RSC advances 8.11 (2018): 5945-5952.https://doi.org/10.1039/C7RA12529A

33. Luo, Hui-Long, et al. "A systematic quality control method of Huangqi decoction: simultaneous determination of eleven flavonoids and seven triterpenoid saponins by UHPLC-MS." Analytical Methods 6.13 (2014): 4593-4601.

32. Wang, Qian, et al. "Identification and pharmacokinetics of multiple constituents in rat plasma after oral administration of Yinchenzhufu decoction." Journal of ethnopharmacology 153.3 (2014): 714-724.https://doi.org/10.1016/j.jep.2014.03.039

31. Wei Wang, Dan-Dan Tian, Bin Zheng, Di Wang, Qing-Rong Tan, Chuan-Yue Wang and Zhang-Jin Zhang Drug Metabolism and Disposition July 2015, 43 (7) 1147-1153; DOI: https://doi.org/10.1124/dmd.114.062653

30. Liu, Zhenhong, et al. "Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury." Cell calcium 88 (2020): 102198.https://doi.org/10.1016/j.ceca.2020.102198

29. Tang Y, Zheng M, Chen YL, Chen J, He Y. Pharmacokinetic Effects of Cinnamic Acid, Amygdalin, Glycyrrhizic Acid and Liquiritin on Ephedra Alkaloids in Rats. European Journal of Drug Metabolism and Pharmacokinetics. 2017 Jun;42(3):527-535. DOI: 10.1007/s1331

28. 温宝庆,李文庆,周妙霞,林坤霞,汪小东,钱正明.茯神饮中化学成分的核壳色谱-四级杆飞行时间质谱联用鉴定和分析[J].时珍国医国药,2020,31(06):1334-1338.

27. 许金国,黄紫炎,沈钱能,李林,王巧晗,王璐,陆兔林,毛春芹.经典名方竹茹汤的指纹图谱及功效关联物质预测分析[J].中国中药杂志,2020,45(23):5599-5606.

26. 刘加瑶,贺怡,田金洁,王利胜,谢波,凌家俊.四逆汤活性成分在血液和心脏部位微透析方法的建立[J].中药新药与临床药理,2020,31(09):1086-1091.

25. 纪万里,周泽华,王婷婷,安叡,梁琨,王新宏.基于UPLC-LTQ-Orbitrap-MS方法分析半夏泻心汤化学成分[J].药物分析杂志,2020,40(10):1736-1750.

24. 王景雁,马书伟,赵馨雨,陈佳佳,刘玉娟,邓莉莉,郭子右,吴清.复方甘草微乳凝胶剂的制备与药效学评价[J].中国中药杂志,2020,45(21):5193-5199.

23. 李壮壮, 张静, 赵绍哲,等. 指纹图谱与化学计量学结合优选柴胡桂枝颗粒水提工艺[J]. 中成药, 2018, v.40(08):199-203.

22. 万嘉洋, 田彦芳, 万海同,等. 麻黄汤有效组分配伍在发热大鼠体内的药动学研究[J]. 中国中药杂志, 2019(10).

21. 杨梦玲, 尤朋涛, 何丽珊,等. 基于UPLC-MS/MS分析胃溃疡模型大鼠口服加味小柴胡颗粒后血浆中8种有效成分的药代动力学[J]. 中国中药杂志, 2018, 43(18).

20. 刘月波章小敏洪冰等. HPLC-DAD法比较不同剂型麻黄汤及其拆方中有效成分含量[J]. 中国中医药科技 2020(1).

19. 程素盼张敏敏梁琰等. HPLC-DAD-ESI-TOF/MS法分析安神补脑液中化学成分[J]. 中成药 2019 041(004):743-748.

18. 张静李壮壮杜宝香等. HPLC法同时测定柴胡桂枝汤中6种成分[J]. 中成药 2018 040(010):2202-2205.

17. 王胜超张振凌刘艳等. 人中黄炮制前后6种化学成分的含量变化及其质量评价[J]. 中国实验方剂学杂志 2017 023(009):11-16.

16. 刘效栓,肖正国,罗燕燕,李喜香,李季文,毕映燕,刘军刚.基于指纹图谱与一测多评技术分析化学转化法富集甘草药渣总黄酮的研究[J].中国中医药信息杂志,2018,25(01):69-73.

15. 李富欣, 于蓓蓓, 孙丹丹,等. 白虎汤合剂质量标准研究[J]. 辽宁中医药大学学报, 2018, 020(003):39-42.

14. 王文静, 于蓓蓓, 孙丹丹,等. 星点设计-效应面法优选白虎汤物质基准的制备工艺[J]. 中华中医药杂志, 2020, v.35(03):505-509.

13. 钱凯杨德森毛芬兰等. 人中黄的高效液相色谱指纹图谱研究[J]. 时珍国医国药 2017 028(005):1125-1127.

12. 曹思瑶宋卓林鑫宇等. 乌拉尔甘草不同溶剂提取物的美白活性比较研究[J]. 长春中医药大学学报 2019 035(001):140-143 146.

11. 张会平蔡丽侠于文帅等. UPLC法研究甘草京大戟反药对配伍后京大戟对甘草中有效成分含量的影响[J]. 沈阳药科大学学报 2019.

10. 李博文,邱智东,董雪莲.缓解体力疲劳保健食品桂芍舒逸口服液指纹图谱研究[J].食品安全质量检测学报,2019,10(07):2007-2011.

9. 赵鑫,张艳雪,李丽,吴鹏,武毅,孙阳恩,齐晓丹,张学兰.甘草饮片炮制工艺的优选[J].山东中医杂志,2020,39(07):726-731.

8. 田彦芳,万海同,朱紫烨,郑平平,虞立,何昱.基于熵权法的多目标筛选甘草黄酮类成分纯化工艺[J].中草药,2016,47(07):1118-1125.

7. 王胜超张振凌于文娜等. 人中黄的HPLC指纹图谱及炮制机理初探[J]. 中药材 2017(05):83-87.

6. 罗琳张豆豆李文斌等. 不同产地栽培甘草药用部位性状和质量的比较分析[J]. 中药材 2018 041(004):829-833.

5. 罗燕燕, 刘效栓, 王红丽,等. 基于化学转化法破壁富集甘草渣总黄酮纯化工艺研究[J]. 陕西中医, 2019, 040(010):1471-1476.

4. 唐映红, 万海同, 陈建真,等. 麻黄汤中9个有效成分的微透析体外回收率研究[J]. 中国中药杂志, 2015(18):3667-3673.

3. 刘效栓, 李喜香, 肖正国,等. 甘草渣中黄酮提取物质量标准研究[J]. 中国中医药信息杂志, 2017(4).

2. 梁琨孙辉安叡等. LC-MS/MS法同时测定护心口服液中11种成分[J]. 中成药 2018 040(001):105-109.

1. 张雪荣毛春芹程雪等. HPLC法同时测定柴仁胶囊中5种成分[J]. 中成药 2017(6).